OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit
http://www.otcpicks.com/microcap.htm today to join this growing community.Our Stocks to Watch today include Adoodle Inc. (OTC: ADDE), Advanced Cell Technology Inc. (OTC: ACTC), Hooper Holmes Inc. (Amex: HH), Trubion Pharmaceuticals Inc. (Nasdaq: TRBN), BankAtlantic Corp. (NYSE: BBX) and Beazer Homes USA Inc. (NYSE: BZH).
For the complete newsletter please visit:
http://www.otcpicks.com/daily-market-movers/index.phpFor more in-depth coverage of small cap stocks visit
http://www.otcpicks.com/microcap.htmADOODLE INCORPORATED (OTC: ADDE)
Company Profile:
http://www.otcpicks.com/adoodle-inc./adoodle-inc.htmThe NOXO Division of Adoodle focuses on Olfaction Perception Altering — Stimulation and Inhibition. Adoodle presently has several NOXO Olfactory Perception Inhibition products. One is a petrolatum based gel version of NOXO, and the other is a Soy based NOXO cream that is easily absorbed into the skin. NOXO effectively inhibits offensive odor perception within the brain rather than just trying to artificially mask odors. The gel or cream is applied under the nostrils from a small one-time use packet and has a myriad of different vertical market applications. If you work in an environment where you are enduring noxious odors, you should try NOXO.
ADVANCED CELL TECHNOLOGY INCORPORATED (OTC: ACTC)
Company Profile:
http://www.otcpicks.com/advanced-cell-technology/advanced-cell-technology.htmAdvanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The company also develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. It also plans to develop and commercialize products for use in the treatment of an array of chronic degenerative diseases and in regenerative repair of acute disease, such as trauma, infarction, and burns. The company has research and license agreements with University of Massachusetts, Wake Forest University, WiCell Research Institute, Inc., Kirin Beer Kabushiki Kaisha, and Start Licensing. Advanced Cell Technology, Inc. is headquartered in Worcester, Massachusetts.
HOOPER HOLMES INCORPORATED (AMEX: HH)
"Up 35.00% in morning trading"
Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. As a leading provider of risk assessment services for the insurance industry, Hooper Holmes provides insurers with the widest range of medical exam, data collection, laboratory testing and underwriting services in the industry. With presence in over 250 markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the U.S. and deliver the results to its customers. Each year we arrange millions of medical exams and process 3.8 million specimens in our laboratory. We provide a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission. We underwrite 300,000 cases annually and complete more than two million telephone interviews.
TRUBION PHARMACEUTICALS INCORPORATED (NASDAQ: TRBN)
"Up 66.38% in morning trading"
Trubion Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases, and cancer. Its lead product candidate TRU-015, which has completed a Phase IIb clinical trial is designed for the treatment of rheumatoid arthritis, non-Hodgkin's lymphoma (NHL), and systemic lupus erythematosus. The company also offers TRU-016, a novel CD37-targeted therapy for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia, and NHL. It has collaboration agreement with Wyeth for the development and commercialization of TRU-015 and other therapeutics directed to CD20, an antigen validated clinical target present on B cells; and SMIP product candidates directed to a small number of targets other than CD20. The company was founded in 1999 and is headquartered in Seattle, Washington.
BANKATLANTIC BANCORP (NYSE: BBX)
"Up 28.35% in morning trading"
BankAtlantic Bancorp, Inc. operates as the holding company for BankAtlantic that provides retail and commercial banking services in Florida. It generates various deposit products, including commercial demand deposit accounts, retail demand deposit accounts, savings accounts, money market accounts, certificates of deposit, various negotiable order of withdrawal accounts and individual retirement accounts, and Keogh retirement accounts. The company’s lending portfolio comprises commercial real estate loans, commercial business loans, standby letters of credit and commitments, consumer loans, small business loans, and residential loans. As of December 31, 2007, it offered its services through approximately 100 branches in southeast and central Florida and the Tampa Bay area, primarily in the Miami-Dade, Broward, Palm Beach, Hillsborough, and Pinellas counties. The company was founded in 1952 and is headquartered in Ft. Lauderdale, Florida.
BEAZER HOMES USA INCORPORATED (NYSE: BZH)
"Up 2.19% in morning trading"
Beazer Homes USA, Inc. engages in the design, building, and sale of single-family and multi-family homes in the United States. It offers homes for entry-level, move-up, luxury, or retirement-oriented buyers. The company also provides title insurance services to its homebuyers. Beazer Homes USA sells its homes through commissioned employees and independent brokers. As of September 30, 2008, it maintained 503 model homes, of which 222 were owned, 196 were financed, and 85 were leased from third parties pursuant to sale and leaseback agreements. The company was founded in 1993 and is headquartered in Atlanta, Georgia.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at
publisher@otcpicks.com.Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has been compensated sixty four thousand free trading shares from a non-controlling third party for ADDE advertising and promotional services. OTCPicks.com has not been compensated for the current ACTC profile coverage. In the past, OTCPicks.com was compensated two thousand dollars by a third party for a one-time ACTC email send.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.